Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT06217926 Completed - Anxiety Clinical Trials

Nursing Students' Attitudes Towards Artificial Intelligence and Exam Anxiety Levels

Start date: January 25, 2024
Phase: N/A
Study type: Interventional

This study was planned to determine nursing students' attitudes towards artificial intelligence and test anxiety levels after using ChatGPT and Google Bard in their education. The study will be carried out in accordance with the research feature of quasi-experimental, pretest-posttest, with 3rd and 4th year nursing students studying at Sinop University Faculty of Health Sciences in the 2023-2024 fall academic year. The research groups are named as follows; Experimental Group: The group that will receive ChatGPT and Google Bard training, Control Group: The group that will not receive ChatGPT and Google Bard training, in other words, the 3rd year students of the nursing department will be referred to as the control group, and the 4th year students will be the experimental group. Educational content; ChatGPT and Google Bard training for senior students of the Faculty of Health Sciences who volunteered to participate in the study was provided by Dr. Lecturer It will be given by member Yasemin Özyer Güvener. After the training is completed, students will be asked to use generative artificial intelligence for educational purposes. During the posttest implementation of the study (one week before the final exams), data collection tools will be applied again to students who continue to volunteer to participate in the research. Key words: nursing students, test anxiety, generative artificial intelligence, ChatGPT, Google Bard

NCT ID: NCT06215456 Recruiting - Anxiety Clinical Trials

Virtual Reality to Reduce Periprocedural Anxiety During Invasive Coronary Angiography

VR InCard
Start date: September 18, 2023
Phase: N/A
Study type: Interventional

Introduction Patients undergoing invasive coronary angiography experience anxiety due to various factors. This can lead to physiological and psychological complications, compromising patient comfort and overall procedural outcomes. Benzodiazepines are commonly used to reduce periprocedural anxiety, although the effect is modest. VR is an promising nonpharmacological intervention that can be used to reduce anxiety in patients undergoing an invasive coronary angiography. Methods and analysis A single-center open-label randomized controlled trial was performed to assess the effectiveness of add-on VR therapy on anxiety in 100 patients undergoing invasive coronary angiography and experiencing anxiety in periprocedural setting. The primary outcome is the NRS anxiety score measured just before obtaining arterial access. Secondary outcomes are physiological measures of anxiety and the State-Trait Anxiety Inventory, Perceived Stress Scale, and IGroup presence questionnaire. The NRS anxiety level and physiological measurements will be taken at five scheduled times between pre procedural, peri and post procedural. The State-Trait Anxiety Inventory and Perceived Stress Scale will be performed prior to coronary angiography and the State-Trait Anxiety Inventory (state form) and the IGroup Presence questionnaire will be performed post-intervention.

NCT ID: NCT06215066 Not yet recruiting - Anxiety Clinical Trials

Effect of Virtual Reality and Progressive Muscle Relaxation on Anxiety and Attention Among Cardiac Care Unit Patients

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

This study aims to: Assess the effect of virtual reality and modified progressive muscle relaxation distraction techniques on anxiety, attention and getting distracted from the external environment among cardiac care unit patients. Research hypotheses: H1: Patients who receive VR intervention have lower Hamilton Anxiety Rating (HAM-A) scores than those who receive modified PMR intervention. H2: Patients who receive VR intervention exhibit improvement in their physiological parameters than those who receive modified PMR intervention. H3: Patients who receive VR intervention have lower Attention/Distraction scores than those who receive modified PMR intervention.

NCT ID: NCT06214039 Recruiting - Clinical trials for Public Speaking Anxiety

Virtual Reality Exposure for Public Speaking Anxiety

VRanx
Start date: February 14, 2024
Phase: N/A
Study type: Interventional

This study aims to examine the efficacy of exposure using virtual reality (VR) for public speaking anxiety in young adults in two treatment arms: a one-session VR exposure therapy with a 4-week online transition intervention versus a three-session VR exposure therapy with a 4-week online transition intervention. Previous studies have demonstrated that one-session therapy (OST) is comparable to prolonged exposure-based therapies in terms of effectively reducing public speaking anxiety. Moreover, VR offers many benefits compared to in-person exposure, namely the ability to produce anxiety-evoking stimuli without having to leave the therapist's room. However, OST VR exposure has not been directly compared to prolonged VR exposure and not for public speaking anxiety.

NCT ID: NCT06213298 Not yet recruiting - Depression Clinical Trials

Effect of Kava on Anxiety and Stress in Cancer Survivors

Start date: June 1, 2024
Phase: Early Phase 1
Study type: Interventional

This is a pilot, two-arm, randomized, blinded, placebo-controlled cross-over clinical trial to study the safety and effect of 14 days of kava on anxiety and physiologic stress in survivors of cancer and its treatment. Participants will be randomized to take either kava first or placebo first. Kava 75 mg or placebo will be taken three time daily (TID) for 14 days (Period 1), followed by a washout period of 14-28 days. Thereafter, the participant will take either placebo or kava TID for 14 days (Period 2), whichever he/she did not take in Period 1.

NCT ID: NCT06213142 Completed - Depression Clinical Trials

Developing the Unified Protocol-Single Session Experience Platform for Adolescent Mental Health

CBToolkit
Start date: June 1, 2023
Phase: N/A
Study type: Interventional

This SBIR Phase I proposal will develop and test the acceptability and feasibility of a new suite of digital Single-Session Interventions, specifically applying Unified Protocol core principles for emotional disorders, to produce a highly accessible, engaging, and scalable product to help address the clinical needs of youth.

NCT ID: NCT06212362 Not yet recruiting - Anxiety Clinical Trials

Stepped Care Versus Group Cognitive Behaviour Therapy for Paediatric Anxiety in Primary Care

Start date: January 8, 2024
Phase: N/A
Study type: Interventional

Objectives: Over the past decade in Sweden, a novel approach to primary healthcare units, known as first-line mental health (FLMH), has been introduced to enhance mental health services for children and adolescents. Through a structured and collaborative method involving experts, clinicians, and patients, a trans-diagnostic psychological intervention for anxiety was formulated based on cognitive behavioural therapy (CBT), designed to align with the FLMH care framework. This study seeks to assess the efficacy of the CBT intervention "Step-by-Step" in a randomised, single-blind, parallel-group, multisite non-inferiority trial. The objective is to investigate whether this treatment is not less effective than the evidence-based Cool Kids program. Rationale for the Study: Childhood anxiety is prevalent and linked to suffering and impairment across various life domains. While cognitive behavioural therapy (CBT) is a proven treatment for anxiety disorders in children, there is a pressing need to enhance access to such interventions. Introducing CBT for childhood anxiety within primary care settings offers an avenue for early and readily available treatment. However, a gap exists in the availability of CBT interventions specifically designed for and assessed within primary care contexts.

NCT ID: NCT06212167 Not yet recruiting - Stroke Clinical Trials

Nursing Interventions on Stroke Patient Care: Quality of Life, Hopelessness, Anxiety and Depression

Start date: February 15, 2024
Phase: N/A
Study type: Interventional

In our research, it was aimed to determine the effect of nursing interventions applied face to face at the time of discharge and then via tele-nursing method to the caregivers of patients in intensive care and diagnosed with stroke, on the quality of life, care burden, hopelessness, anxiety and depression levels of the caregivers. This research will be conducted as a randomized, pre-test, post-test single group intervention study, at the Neurology Intensive Care Unit of Sakarya University Training and Research Hospital, between March and June 2023. With a 95% confidence interval, 5% margin of error, 0.54 effect size and 95% representativeness of the population, the group was calculated as 47 people, and the sample was determined as 56 people in total, with 20% reserve. The sample of the study will be selected by simple random sampling method among the caregivers of stroke patients who meet the inclusion criteria and agree to participate in the research. During the discharge process, Information Forms, Zarit Caregiving Burden Scale, Beck Hopelessness Scale, Adult Caregiver Quality of Life Survey, and Hospital Anxiety Depression Scale will be administered face to face to the participants as a pre-test. 12 weeks after the first measurement, Zarit Caregiving Burden Scale, Beck Hopelessness Scale, Adult Caregiver Quality of Life Questionnaire, Hospital Anxiety Depression Scale will be administered as posttest. In addition to routine discharge training, participants will be provided with 'Education and Care Practices for Stroke Patients'. These applications; It will be performed for those who care for stroke patients in the hospital for a week, and then at home, twice a week, for a total of 7 weeks, via telenursing method. Written consent will be obtained from caregivers after explaining the purpose of the research and the purpose for which the results will be used. Participants will be informed that their information will not be shared with others and the confidentiality policy will be adhered to. In order to make comparisons before and after the training, participants will be asked to fill out data collection forms with a nickname they can easily remember and not forget in the pre-test. They will be asked to write the same pseudonyms when filling out the post-test data collection forms. Participants will be asked to fill out data collection forms individually, but it will be stated that they can contact the researchers if they have questions.

NCT ID: NCT06206057 Not yet recruiting - Anxiety Clinical Trials

The Relationship Between Leisure Activities and Aging Anxiety in Women

Start date: May 1, 2024
Phase:
Study type: Observational

The goal of this observational study is to learn about the effect of leisure activities on aging anxiety of middle-aged (45-59) women. The main question it aims to answer is: Do the leisure activities (doing sports, playing music instruments, doing handicrafts, writing, taking care of a pet, growing plants, dancing etc.) affect the aging anxiety level of middle-aged women? Participants will be required to fill out a form querying their socio-demographic information, medical histories, and regular leisure activities. Subsequently, the "Aging Anxiety Scale for Middle-Aged Women" will be applied.

NCT ID: NCT06199206 Completed - Anxiety and Fear Clinical Trials

The Effect of Therapeutic Play on Children's Anxiety and Fear Before Lumbar Puncture

Start date: January 15, 2024
Phase: N/A
Study type: Interventional

The study will be conducted with the randomized controlled experimental method. The children who attended the pediatric department will divide into two groups via randomization in the computer environment. After random selection, children in the intervention group will play a therapeutic game before the lumbar puncture procedure. Children in the control group will not undergo any procedure before the lumbar puncture procedure. Parents will be present with their children in both groups during the procedure. While the child's anxiety and fear level is measured, the parent's anxiety level will also be measured.